Logo image of JXJT

JX Luxventure Ltd (JXJT) Stock Analyst Earnings Estimates

NASDAQ:JXJT - Nasdaq - MHY460023028 - Common Stock

0.8075  -0.02 (-2.96%)

After market: 0.8 -0.01 (-0.93%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023
Revenue
YoY % growth
JXJT revenue by date.JXJT revenue by date.
54.04M
3,932.84%
79.87M
47.80%
31.841M
-60.13%
EBITDA
YoY % growth
JXJT ebitda by date.JXJT ebitda by date.
-6.61M
-2,773.91%
-54.63M
-726.48%
3.677M
106.73%
EBIT
YoY % growth
JXJT ebit by date.JXJT ebit by date.
-7.37M
-637.00%
-55.36M
-651.15%
3.391M
106.13%
Operating Margin
JXJT operating margin by date.JXJT operating margin by date.
-13.64%-69.31%10.65%
EPS
YoY % growth
JXJT eps by date.JXJT eps by date.
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
JXJT Yearly EPS VS EstimatesJXJT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth
28.183M
30.90%
%
Q4 2023
Q2Q % growth
31.841M
-60.13%
%
Q2 2023
Q2Q % growth
21.53M
-58.19%
%
Q4 2022
Q2Q % growth
79.87M
47.80%
%
Q2 2022
Q2Q % growth
51.49M
305.11%
%
Q4 2021
Q2Q % growth
54.04M
3,932.84%
%
Q4 2020
Q2Q % growth
1.34M
-91.86%
%
JXJT Yearly Revenue VS EstimatesJXJT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A